Volume 271, Number 33, Issue of August 16, 1996 pp. 20082-20087
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Functional Importance of Amino-terminal Domain of Shc for Interaction with Insulin and Epidermal Growth Factor Receptors in Phosphorylation-independent Manner

(Received for publication, April 29, 1996)

From the First Department of Medicine, Toyama Medical and Pharmaceutical University, Toyama, 930-01 Japan

Shc has two distinct domains, amino-terminal and SH2 domain, which can interact with activated growth factor receptors. Shc interacts with insulin receptor via Shc-amino-terminal (N) domain, whereas Shc associates with epidermal growth factor (EGF) receptor through both Shc-N and -SH2 domains. In accordance with the different functional roles between insulin and EGF receptors, EGF stimulated tyrosine phosphorylation of Shc faster than insulin. To clarify the functional importance of three distinct Shc domains on insulin and EGF signaling, we microinjected glutathione S-transferase (GST) fusion proteins containing the amino terminus plus collagen homology domain (NCH), collagen homology domain (CH), and Src homology 2 domain (SH2) into Rat1 fibroblasts expressing insulin receptors (HIRc). Bromodeoxyuridine (BrdUrd) incorporation into newly synthesized DNA was subsequently studied to assess the importance of the three distinct domains of Shc. Microinjection of the NCH-GST fusion protein inhibited BrdUrd incorporation induced by both EGF and insulin, whereas microinjection of the SH2-GST fusion protein inhibited EGF, but not insulin stimulation of DNA synthesis. Neither EGF- nor insulin-induced BrdUrd incorporation was inhibited by the CH-GST fusion protein. Following EGF or insulin stimulation, Shc is phosphorylated on single Tyr-317 residue serving as a docking site for Grb2. Microinjection of Shc-N+CH GST fusion protein with Tyr-317  Phe replacement (Y317F) also inhibited insulin stimulation of DNA synthesis. Next, we stably overexpressed wild-type Shc or Y317F mutant Shc into HIRc cells. Insulin-induced tyrosine phosphorylation of IRS-1 was compared among the transfected cell lines, since IRS-1 and Shc could competitively interact with insulin receptor. Insulin-stimulated tyrosine phosphorylation of IRS-1 was decreased in both WT-Shc and Y317F-Shc cells compared with that in HIRc cells. Furthermore, overexpression of the Shc-SH2 domain or Shc-N+CH domain with Y317F mutation interfered with EGF-stimulated endogenous Shc phosphorylation. These results suggest that the amino terminus domain of Shc is functionally important in insulin- and EGF-induced cell cycle progression and that the phosphorylation of Shc Tyr-317 residue is independent of Shc interaction with these receptors.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. Audero, I. Cascone, F. Maniero, L. Napione, M. Arese, L. Lanfrancone, and F. Bussolino Adaptor ShcA Protein Binds Tyrosine Kinase Tie2 Receptor and Regulates Migration and Sprouting but Not Survival of Endothelial Cells J. Biol. Chem., March 26, 2004; 279(13): 13224 - 13233. [Abstract] [Full Text] [PDF]

				T. Sasaoka, M. Ishiki, T. Wada, H. Hori, H. Hirai, T. Haruta, H. Ishihara, and M. Kobayashi Tyrosine Phosphorylation-Dependent and -Independent Role of Shc in the Regulation of IGF-1-Induced Mitogenesis and Glycogen Synthesis Endocrinology, December 1, 2001; 142(12): 5226 - 5235. [Abstract] [Full Text] [PDF]

				Y.-N. Kim, G. J. Wiepz, A. G. Guadarrama, and P. J. Bertics Epidermal Growth Factor-stimulated Tyrosine Phosphorylation of Caveolin-1. ENHANCED CAVEOLIN-1 TYROSINE PHOSPHORYLATION FOLLOWING ABERRANT EPIDERMAL GROWTH FACTOR RECEPTOR STATUS J. Biol. Chem., March 10, 2000; 275(11): 7481 - 7491. [Abstract] [Full Text] [PDF]

				B. T. Solow, S. Harada, B. J. Goldstein, J. A. Smith, M. F. White, and L. Jarett Differential Modulation of the Tyrosine Phosphorylation State of the Insulin Receptor by IRS (Insulin Receptor Subunit) Proteins Mol. Endocrinol., October 1, 1999; 13(10): 1784 - 1798. [Abstract] [Full Text]

				T. Wada, T. Sasaoka, M. Ishiki, H. Hori, T. Haruta, H. Ishihara, and M. Kobayashi Role of the Src Homology 2 (SH2) Domain and C-Terminus Tyrosine Phosphorylation Sites of SH2-Containing Inositol Phosphatase (SHIP) in the Regulation of Insulin-Induced Mitogenesis Endocrinology, October 1, 1999; 140(10): 4585 - 4594. [Abstract] [Full Text]

				L. E. Stevenson, K. S. Ravichandran, and A. R. Frackelton Jr. Shc Dominant Negative Disrupts Cell Cycle Progression in Both G0-G1 and G2-M of ErbB2-positive Breast Cancer Cells Cell Growth Differ., January 1, 1999; 10(1): 61 - 71. [Abstract] [Full Text]

				B. Kim, H.-L. Cheng, B. Margolis, and E. L. Feldman Insulin Receptor Substrate 2 And Shc Play Different Roles In Insulin-like Growth Factor I Signaling J. Biol. Chem., December 18, 1998; 273(51): 34543 - 34550. [Abstract] [Full Text] [PDF]

				F. Walker, A. Kato, L. J. Gonez, M. L. Hibbs, N. Pouliot, A. Levitzki, and A. W. Burgess Activation of the Ras/Mitogen-Activated Protein Kinase Pathway by Kinase-Defective Epidermal Growth Factor Receptors Results in Cell Survival but Not Proliferation Mol. Cell. Biol., December 1, 1998; 18(12): 7192 - 7204. [Abstract] [Full Text]

				J. P. O'Bryan, Q. T. Lambert, and C. J. Der The Src Homology 2 and Phosphotyrosine Binding Domains of the ShcC Adaptor Protein Function as Inhibitors of Mitogenic Signaling by the Epidermal Growth Factor Receptor J. Biol. Chem., August 7, 1998; 273(32): 20431 - 20437. [Abstract] [Full Text] [PDF]

				D. Thomas and R. A. Bradshaw Differential Utilization of ShcA Tyrosine Residues and Functional Domains in the Transduction of Epidermal Growth Factor-induced Mitogen-activated Protein Kinase Activation in 293T Cells and Nerve Growth Factor-induced Neurite Outgrowth in PC12 Cells. IDENTIFICATION OF A NEW Grb2·Sos1 BINDING SITE J. Biol. Chem., August 29, 1997; 272(35): 22293 - 22299. [Abstract] [Full Text] [PDF]

				M. L. Goalstone, J. W. Leitner, P. Berhanu, P. M. Sharma, J. M. Olefsky, and B. Draznin Insulin Signals to Prenyltransferases via the Shc Branch of Intracellular Signaling J. Biol. Chem., April 13, 2001; 276(16): 12805 - 12812. [Abstract] [Full Text] [PDF]

				A. Caselli, M. L. Taddei, G. Manao, G. Camici, and G. Ramponi Tyrosine-phosphorylated Caveolin Is a Physiological Substrate of the Low Mr Protein-Tyrosine Phosphatase J. Biol. Chem., May 25, 2001; 276(22): 18849 - 18854. [Abstract] [Full Text] [PDF]